ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/09 | 1,982 | 1,985 | 1,901 | 1,909 | -64 | -3.2% | 1,198,800 |
| 2022/11/08 | 1,997 | 2,021 | 1,971 | 1,973 | -9 | -0.5% | 552,200 |
| 2022/11/07 | 1,984 | 1,994 | 1,954 | 1,982 | -22 | -1.1% | 556,300 |
| 2022/11/04 | 2,000 | 2,012 | 1,982 | 2,004 | -7 | -0.3% | 480,300 |
| 2022/11/02 | 2,017 | 2,030 | 1,972 | 2,011 | -19 | -0.9% | 909,800 |
| 2022/11/01 | 2,037 | 2,052 | 2,003 | 2,030 | -3 | -0.1% | 592,900 |
| 2022/10/31 | 2,078 | 2,088 | 2,023 | 2,033 | -31 | -1.5% | 983,900 |
| 2022/10/28 | 2,050 | 2,081 | 2,031 | 2,064 | -21 | -1% | 865,000 |
| 2022/10/27 | 2,073 | 2,116 | 2,068 | 2,085 | -9 | -0.4% | 1,076,000 |
| 2022/10/26 | 1,992 | 2,100 | 1,992 | 2,094 | +114 | +5.8% | 2,071,700 |
| 2022/10/25 | 1,948 | 1,982 | 1,944 | 1,980 | +39 | +2% | 560,300 |
| 2022/10/24 | 1,946 | 1,967 | 1,932 | 1,941 | ±0 | ±0% | 596,600 |
| 2022/10/21 | 1,961 | 1,972 | 1,924 | 1,941 | -31 | -1.6% | 763,600 |
| 2022/10/20 | 2,003 | 2,008 | 1,939 | 1,972 | -46 | -2.3% | 1,432,600 |
| 2022/10/19 | 2,036 | 2,055 | 2,008 | 2,018 | -12 | -0.6% | 825,300 |
| 2022/10/18 | 2,027 | 2,034 | 1,994 | 2,030 | +14 | +0.7% | 1,094,100 |
| 2022/10/17 | 2,030 | 2,084 | 2,016 | 2,016 | +41 | +2.1% | 2,203,200 |
| 2022/10/14 | 1,900 | 1,984 | 1,897 | 1,975 | +105 | +5.6% | 1,598,800 |
| 2022/10/13 | 1,897 | 1,904 | 1,862 | 1,870 | -27 | -1.4% | 600,800 |
| 2022/10/12 | 1,913 | 1,927 | 1,881 | 1,897 | -13 | -0.7% | 712,500 |
| 2022/10/11 | 1,895 | 1,928 | 1,890 | 1,910 | +6 | +0.3% | 583,800 |
| 2022/10/07 | 1,948 | 1,966 | 1,896 | 1,904 | -42 | -2.2% | 920,600 |
| 2022/10/06 | 1,911 | 1,963 | 1,908 | 1,946 | +31 | +1.6% | 1,105,600 |
| 2022/10/05 | 1,903 | 1,927 | 1,883 | 1,915 | -8 | -0.4% | 791,900 |
| 2022/10/04 | 1,912 | 1,925 | 1,880 | 1,923 | +25 | +1.3% | 873,400 |
| 2022/10/03 | 1,840 | 1,900 | 1,811 | 1,898 | +65 | +3.5% | 965,000 |
| 2022/09/30 | 1,865 | 1,873 | 1,815 | 1,833 | -13 | -0.7% | 732,400 |
| 2022/09/29 | 1,830 | 1,886 | 1,816 | 1,846 | +56 | +3.1% | 1,037,600 |
| 2022/09/28 | 1,795 | 1,863 | 1,782 | 1,790 | +6 | +0.3% | 1,360,700 |
| 2022/09/27 | 1,772 | 1,798 | 1,748 | 1,784 | +22 | +1.2% | 786,100 |
| 2022/09/26 | 1,777 | 1,818 | 1,762 | 1,762 | -47 | -2.6% | 1,564,800 |
| 2022/09/22 | 1,849 | 1,879 | 1,790 | 1,809 | -72 | -3.8% | 2,269,700 |
| 2022/09/21 | 1,888 | 1,891 | 1,846 | 1,881 | -25 | -1.3% | 1,041,200 |
| 2022/09/20 | 1,940 | 1,950 | 1,843 | 1,906 | -33 | -1.7% | 1,788,500 |
| 2022/09/16 | 1,952 | 1,968 | 1,896 | 1,939 | +17 | +0.9% | 1,783,000 |
| 2022/09/15 | 1,926 | 1,954 | 1,910 | 1,922 | +19 | +1% | 1,197,800 |
| 2022/09/14 | 1,843 | 1,919 | 1,841 | 1,903 | +11 | +0.6% | 1,287,900 |
| 2022/09/13 | 1,846 | 1,920 | 1,840 | 1,892 | +44 | +2.4% | 1,543,400 |
| 2022/09/12 | 1,818 | 1,848 | 1,803 | 1,848 | +41 | +2.3% | 1,204,600 |
| 2022/09/09 | 1,707 | 1,816 | 1,696 | 1,807 | +108 | +6.4% | 1,951,400 |
| 2022/09/08 | 1,714 | 1,726 | 1,685 | 1,699 | +14 | +0.8% | 814,800 |
| 2022/09/07 | 1,714 | 1,726 | 1,675 | 1,685 | -30 | -1.7% | 915,800 |
| 2022/09/06 | 1,738 | 1,752 | 1,711 | 1,715 | -23 | -1.3% | 772,200 |
| 2022/09/05 | 1,708 | 1,745 | 1,694 | 1,738 | +25 | +1.5% | 963,400 |
| 2022/09/02 | 1,750 | 1,773 | 1,711 | 1,713 | -27 | -1.6% | 1,083,800 |
| 2022/09/01 | 1,737 | 1,757 | 1,724 | 1,740 | -6 | -0.3% | 686,500 |
| 2022/08/31 | 1,740 | 1,750 | 1,731 | 1,746 | +6 | +0.3% | 466,200 |
| 2022/08/30 | 1,730 | 1,740 | 1,703 | 1,740 | +26 | +1.5% | 830,300 |
| 2022/08/29 | 1,693 | 1,729 | 1,678 | 1,714 | -47 | -2.7% | 1,462,300 |
| 2022/08/26 | 1,742 | 1,795 | 1,738 | 1,761 | +19 | +1.1% | 1,316,800 |
501～
550
件表示中 / 4975件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.27倍 | 1.47倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
